IBA is partnering with RaySearch Laboratories AB (publ) to advance adaptive proton therapy in combining respective technologies. In both RayStation® and RayCare**, as well as in the IBA delivery solutions, combined features dedicated software interfaces allow for seamless workflow integration with optimized performance. A real-time demonstration will be displayed at IBA's booth.
For more information about the online adaptive proton therapy workflow, read the press release.
Ad Statistics
Times Displayed: 22487
Times Visited: 455 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
IBA Proton Therapy Conference
On Saturday, April 21st, 2018, IBA is hosting a symposium in Barcelona with presentations from experienced speakers in proton therapy:
Professor Debus, from Heidelberg University Hospital, will explain the benefits of proton therapy for key clinical indications;
The model based approach for patient selection will be presented by Professor Langendijk from the University Medical Center in Groningen;
Professor Depuydt, from ParTICLe Proton Therapy UZ Leuven, will describe the integration of proton therapy in an existing oncology center.
Registration to the IBA proton therapy event is available here.
About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.
IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com
Back to HCB News
